6505--770-25-1-801-0131 -National CMOP DORZOLAMIDE/TIMOLOL -(VA-25-00027395)
ID: 36C77025Q0163Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/4f6aa24313904855aab81a7a0e6fc204/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting bids for the procurement of Dorzolamide 22.3/Timolol 6.8mg/ml ophthalmic solution as part of its National Consolidated Mail Outpatient Pharmacy (CMOP) program. This solicitation requires vendors to submit a signed cover page, pricing schedule, and documentation such as a valid state distributor license and a Trade Agreements Act certificate, ensuring compliance with regulatory standards for pharmaceutical products. The procurement is critical for providing quality healthcare services to veterans, emphasizing the importance of product safety, therapeutic equivalence, and adherence to delivery schedules. Interested vendors must submit their quotes by March 5, 2025, at 3:00 PM Central Time, and can contact Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov for further inquiries.

    Point(s) of Contact
    Kelley CunninghamContracting Officer
    (913) 684-0140
    kelley.cunningham@va.gov
    Files
    Title
    Posted
    36C77025Q0163_1.docx
    The document outlines a federal procurement solicitation (SF 1449) by the Department of Veterans Affairs (VA) for pharmaceutical products, specifically Dorzolamide 22.3/Timolol 6.8mg/ml solution. It details the parameters for bidders, including submission requirements (e.g., signed cover page, pricing schedule, state distributor license), evaluation of compliance, and necessary documentation like the Trade Agreements Act Certificate. The solicitation emphasizes to suppliers the requirements for shippable products, barcoding standards, therapeutic equivalence, and processes for handling recalls. It specifies delivery schedules to various VA CMOP facilities, payment methods, and established terms and conditions under which the contract operates, including the contractor's obligations regarding invoicing and product acceptance. The document incorporates numerous Federal Acquisition Regulation (FAR) clauses to establish compliance with regulatory standards. Overall, the purpose is to support the procurement process for pharmaceutical products that meet stringent quality, safety, and regulatory requirements for veteran healthcare services. The structure systematically organizes key sections such as solicitation details, proposal instructions, contract clauses, and requirements for delivery and invoicing.
    36C77025Q0163.docx
    The Department of Veterans Affairs (VA) is preparing to solicit procurement for DORZOLAMIDE/TIMOLOL ophthalmic solution across multiple Consolidated Mail Outpatient Pharmacies (CMOP). The presolicitation notice outlines that quantities of the product will be delivered to various locations including Leavenworth, Chelmsford, Tucson, Lancaster, Murfreesboro, Hines, and Ladson. The solicitation number is 36C77025Q0163, with an estimated issue date of February 28, 2025, and a response deadline of March 5, 2025. The contract falls under full and open competition, with a delivery timeframe of 10 days after receipt of order. Interested vendors must provide necessary documentation including a state wholesale distributor license, a signed solicitation cover page, a price schedule, and compliance certificates. All submissions should be directed to Contracting Officer Kelley Cunningham via email. This solicitation emphasizes the VA’s mission to maintain an efficient supply chain while ensuring compliance with federal regulations regarding pharmaceuticals.
    S02_Pricing Schedule_Q0163.xlsx
    The document outlines a Request for Quotation (RFQ) from the Veterans Affairs (VA) for pharmaceutical supplies as part of the Consolidated Mail Outpatient Pharmacy (CMOP) program. It specifies the required submission documents, including the solicitation cover page (SF1449), a quote spreadsheet, a valid state wholesale distributor license, and a Trade Agreement Act (TAA) certificate, highlighting that only TAA-compliant quotes will be considered. The RFQ has a posting date of February 28, 2025, with a closing deadline of March 5, 2025, at 3:00 PM Central Time. Vendors must adhere to expiration guidelines by ensuring that all products have a minimum shelf life of one year upon delivery. The document lists various line items for DORZOLAMIDE and TIMOLOL ophthalmic solutions, stating quantities and corresponding details for each item requested. Vendors are directed to submit their quotes via email, including any adjustments made for product counts and expiration dates in the provided comments section. This RFQ serves the goal of procuring necessary medical supplies for VA facilities, ensuring compliance with established regulations and maintaining quality standards for pharmaceuticals delivered to veterans.
    Similar Opportunities
    6505--Mycophenolate Mofetil RFP
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Mycophenolate Mofetil capsules and tablets under Solicitation Number 36E79725R0010, aimed at establishing national pricing for these pharmaceutical products. The contract is intended to support various government health care facilities, including those under the Department of Defense and Indian Health Service, ensuring compliance with FDA standards and the Drug Supply Chain Security Act. Offerors are required to submit pricing for both the base year and four option years, with a deadline for submissions extended to March 4, 2025, at 2:30 PM CST, and must acknowledge receipt of this amendment to avoid rejection of their offers. Interested parties can contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further information.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Diclofenac Sodium (NA) 1% Gel
    Buyer not available
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Diclofenac Sodium (NA) 1% Gel, intended for use in its pharmaceutical programs as well as those of the Department of Defense (DoD). Contractors are required to provide pricing for a base year along with four one-year option years, ensuring compliance with federal drug regulations and the Drug Supply Chain Security Act (DSCSA). This procurement is critical for maintaining a reliable supply of pharmaceutical products that meet stringent manufacturing standards and public health requirements. Interested parties must submit their offers by March 4, 2025, at 2:30 PM Central Time, and can contact Contract Specialist Ray Roldan at Raymond.Roldan@va.gov for further information.
    6505--Bevacizumab Injection
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Bevacizumab injections, a critical pharmaceutical product used in various healthcare settings for veterans. Vendors are required to meet specific criteria, including providing unique National Drug Codes (NDC) and adhering to the Drug Supply Chain Security Act regulations, as the contract aims to ensure a reliable supply of this medication across government health care facilities. The selected contractor will be responsible for multiple line items of different Bevacizumab formulations, maintaining compliance with FDA manufacturing practices, and submitting quarterly sales reports, including cost recovery fees. Interested vendors should contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov for further details, with submissions due by the specified deadlines outlined in the solicitation document.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0168 762-25-2-040-1176 -Tucson CMOP HYDROXYCHLOROQUINE SULFATE
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Hydroxychloroquine Sulfate 200mg tablets, with a total quantity of 5,412 to be delivered to the CMOP facility in Tucson, Arizona. This presolicitation, identified by solicitation number 36C77025Q0168, is set aside for small businesses and requires compliance with the Buy American statute, necessitating quotes for both foreign and domestic products. Hydroxychloroquine is a critical pharmaceutical used in the treatment of various conditions, making this procurement essential for the healthcare services provided to veterans. Interested vendors must submit their proposals by March 5, 2025, at 09:00 Central Time, and can direct inquiries to Contract Specialist Michael W. McAlhaney via email at Michael.McAlhaney@va.gov or by phone at (913) 684-0134.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0167 762-25-2-040-1129 -Tucson CMOP SERTRALINE HCL
    Buyer not available
    The Department of Veterans Affairs is seeking quotations for the procurement of Sertraline HCL 100MG tablets (500 count) under solicitation RFQ: 36C77025Q0167. This procurement aims to ensure compliance with the Drug Supply Chain Security Act (DSCSA) and requires suppliers to provide documentation such as a signed SF1449 solicitation cover page, a pricing schedule, and a completed Buy American Certificate, emphasizing the importance of domestic sourcing. The expected delivery date for the pharmaceuticals is March 21, 2025, with a submission deadline for offers set for March 4, 2025. Interested parties should contact Contracting Specialist Michael W McAlhaney at Michael.McAlhaney@va.gov for further information.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Rituximab 10mg/ml and its biosimilars, aimed at establishing a reliable pharmaceutical supply source for government healthcare facilities. Bidders are required to provide unique National Drug Code (NDC) numbers for their products and include a 0.5% Cost Recovery Fee in their pricing, with the contract covering a base year and four optional subsequent years. This procurement is critical for ensuring consistent product availability and pricing based on estimated annual usage, while adhering to FDA regulations and the Drug Supply Chain Security Act (DSCSA) for safety and traceability. Interested suppliers must submit their proposals by March 11, 2025, at 2:30 PM CT, and can contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further information.
    Tucson CMOP DIVALPROEX
    Buyer not available
    The Department of Veterans Affairs is seeking qualified small businesses to supply Divalproex Sodium 125mg Sprinkle Capsules under Contract Number 36C77025Q0131 for the Tucson CMOP. This procurement requires vendors to comply with strict shipping regulations, provide National Drug Codes (NDC), and ensure product availability while adhering to the Drug Supply Chain Security Act documentation. The pharmaceuticals are essential for the healthcare of veterans, emphasizing the government's commitment to quality and reliability in pharmaceutical supplies. Interested vendors must submit their proposals, including a signed SF 1449 form and a valid wholesale distributor license, by 4:00 PM CST on March 6, 2025, with all submissions directed to Sarah Fry at sarah.fry2@va.gov.
    6505--Hydroxychloroquine SO4 Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a Request for Proposal (RFP) for the procurement of Hydroxychloroquine SO4 Tablets, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will cover an estimated annual requirement of 163,395 bottles of 100-count and 25,853 bottles of 500-count Hydroxychloroquine tablets, with a contract period of one year and four optional one-year extensions. This procurement is critical for maintaining essential medications within veteran and federal healthcare programs. Interested parties should monitor SAM.gov for updates and direct inquiries to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov or (708) 786-4980, with submissions due by March 26, 2025.
    6505--Insulin (VA-25-00026482)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of insulin and related pharmaceutical products under the solicitation titled "6505--Insulin (VA-25-00026482)." This procurement aims to establish a reliable supply source for the Department of Veterans Affairs and the Department of Defense, requiring offerors to submit competitive pricing for a base year plus four option years, including a 0.5% Cost Recovery Fee. Compliance with the Drug Supply Chain Security Act (DSCSA), adherence to current good manufacturing practices (cGMP), and provision of unique National Drug Codes (NDC) for the offered products are critical requirements. Interested parties should direct inquiries to Contract Specialist Billy Fong at Billy.Fong@va.gov, with proposals due by the specified deadline outlined in the solicitation document.